Japan, Novartis Negotiate Canceling Rest Of H1N1 Vaccine Doses
This article was originally published in PharmAsia News
Executive Summary
Japan's health ministry and Novartis have agreed to cancel the rest of the undelivered supply of H1N1 vaccine it ordered to deal with a pandemic